Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.13.3 (
histidine kinase
)
2,405
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Emergence of resistance to polymyxins in
Pseudomonas aeruginosa
is mainly due to mutations in two-component systems that promote the addition of 4-amino-4-deoxy-l-arabinose to the lipopolysaccharide (LPS) through upregulation of operon
arnBCADTEF-
ugd
(
arn
) expression. Here, we demonstrate that mutations occurring in different domains of
histidine kinase
PmrB or in response regulator PmrA result in coresistance to aminoglycosides and colistin. All seventeen clinical strains tested exhibiting such a cross-resistance phenotype were found to be
pmrAB
mutants. As shown by gene deletion experiments, the decreased susceptibility of the mutants to aminoglycosides was independent from operon
arn
but required the efflux system MexXY-OprM and the products of three genes, PA4773-PA4774-PA4775, that are cotranscribed and activated with genes
pmrAB
Gene PA4773 (annotated as
speD2
in the PAO1 genome) and PA4774 (
speE2
) are predicted to encode enzymes involved in biosynthesis of polyamines. Comparative analysis of cell surface extracts of an
in vitro
selected
pmrAB
mutant, called AB16.2, and derivatives lacking PA4773, PA4774, and PA4775 revealed that these genes were needed for norspermidine production via a pathway that likely uses 1,3-diaminopropane, a precursor of polyamines. Altogether, our results suggest that norspermidine decreases the self-promoted uptake pathway of aminoglycosides across the outer membrane and, thereby, potentiates the activity of efflux pump MexXY-OprM.
...
PMID:Production of Norspermidine Contributes to Aminoglycoside Resistance in
pmrAB
Mutants of Pseudomonas aeruginosa. 3138 68